Effects of Eugenol on Alzheimer’s Disease-like Manifestations in Insulin- and Aβ-Induced Rat Models
- 1 March 2019
- journal article
- research article
- Published by Springer Nature in Neurophysiology
- Vol. 51 (2) , 114-119
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Protein Folding and Aggregation into Amyloid: The Interference by Natural Phenolic CompoundsInternational Journal of Molecular Sciences, 2013
- Microglia Function in Alzheimer’s DiseaseFrontiers in Pharmacology, 2012
- Neuroprotective strategies involving ROS in Alzheimer diseaseFree Radical Biology and Medicine, 2011
- (−)-Epigallocatechin-3-Gallate (EGCG) Maintains κ-Casein in Its Pre-Fibrillar State without Redirecting Its Aggregation PathwayJournal of Molecular Biology, 2009
- Systematic review of information and support interventions for caregivers of people with dementiaBMC Geriatrics, 2007
- The Medial Temporal Lobe and Recognition MemoryAnnual Review of Neuroscience, 2007
- The Effect of Intrahippocampal Beta Amyloid (1‐42) Peptide Injection on Oxidant and Antioxidant Status in Rat BrainAnnals of the New York Academy of Sciences, 2007
- C‐terminal fragment of amyloid precursor protein induces astrocytosisJournal of Neurochemistry, 2001
- Formation of insulin amyloid fibrils followed by FTIR simultaneously with CD and electron microscopyProtein Science, 2000
- Rodent models of Alzheimer's disease: Rat aβ infusion approaches to amyloid depositsNeurobiology of Aging, 1996